Affiliation:
1. Faculty of Health Sciences, Hokkaido University, Sapporo 060-0812, Japan
2. Department of Physiology, The University of Tennessee Health Science Center, Memphis, TN 38163, USA
3. Graduate School of Global Food Resources, Hokkaido University, Sapporo 060-0812, Japan
Abstract
Non-alcoholic fatty liver disease (NAFLD), a complex liver disorder that can result in non-alcoholic steatohepatitis, cirrhosis, and liver cancer, is the accumulation of fat in the liver seen in people due to metabolic dysfunction. The pathophysiology of NAFLD is influenced by several variables, such as metabolic dysregulation, oxidative stress, inflammation, and genetic susceptibility. This illness seriously threatens global health because of its link to obesity, insulin resistance, type 2 diabetes, and other metabolic disorders. In recent years, lipid–NAFLD crosstalk has drawn a lot of interest. Through numerous methods, lipids have been connected to the onset and advancement of the illness. The connection between lipids and NAFLD is the main topic of the current review, along with the various therapeutic targets and currently available drugs. The importance of hepatic lipid metabolism in the progression of NAFLD is summarized with the latest results in the field.
Funder
Japanese Society for the Promotion of Science KAKENHI Grants